Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Fostemsavir on Oral Contraceptive PK
NCT02480881Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fostemsavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Concentration-Time Curve Over a Dosing Interval. Started Jul 2015; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02480881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480881.